Novo Nordisk CEO tells investors to expect weight-loss drug pricing to go down before it comes back up
Recently-appointed CEO Mike Doustdar has repeatedly reset expectations since his arrival. Pricing and regulatory pressure is fierce and pessimistic revenue guidance has seen the stock clobbered 17% in Copenhagen.
Related Posts
Don’t expect lower prices now that the Supreme Court has ruled against Trump’s tariffs
The Supreme Court’s decision to strike down many of President Donald Trump’s tariffs is a massive blow to the president’s agenda. But f...
Wayfair’s stock sinks, as investors worry expansion plans will hurt profits
Wayfair’s stock suffered its worst postearnings reaction in nearly four years, after the company unexpectedly swung to a net loss for t...
Figma’s stock soars as AI earnings momentum helps ease investors’ doubts
Figma’s revenue grew 40% in the fourth quarter as net dollar retention rate increased to 136%
Goldman Sachs CEO Owns ‘Very Little’ Bitcoin, Backs Bessent on Clarity Act
Goldman Sachs CEO David Solomon said Wednesday that cr...
U.S. stock futures inch higher as investors digest ongoing tech selloff
U.S. stock futures were little changed late Monday, following another brutal week for tech stocks.
Crypto investors who don’t fill out this new tax form the right way could overpay on their taxes
Crypto investors can expect to receive a new tax form this year from exchanges such as Coinbase and Robinhood.
Europe must be ready to fight, PM tells Munich Security Conference
The prime minister's speech comes after a tumultuous week in his political career back home.
Rubio tells Munich security forum that US and Europe belong together
Rubio tells Munich security forum that US and Europe belong together
Newsweek CEO Dev Pragad warns publishers: adapt as AI becomes news gateway
Author: Dev Pragad, CEO, NewsweekAs artificial intelligence platforms increasingly mediate how people encounter news, media leader...